Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

Abstract Severe COVID-19 infection results in significant immune dysregulation resulting from excessive recruitment and activation of neutrophils. The aim of this study was to confirm feasibility, initial safety and detect signal of efficacy of a non-propriety device delivered using an intermittent...

Full description

Bibliographic Details
Main Authors: Sandrine Lemoine, Jarrin Penny, Douglas D. Fraser, Fabio R. Salerno, Justin Dorie, Tanya Tamasi, Robert Arntfield, Andrew House, Marat Slessarev, Christopher W. McIntyre
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21944-4

Internet

https://doi.org/10.1038/s41598-022-21944-4

Similar Items